Blocking mammalian target of rapamycin (mTOR) improves neuropathic pain evoked by spinal cord injury
Spinal cord injury (SCI) is an extremely serious type of physical trauma observed in clinics. Neuropathic pain resulting from SCI has a lasting and significant impact on most aspects of daily life. Thus, a better understanding of the molecular pathways responsible for the cause of neuropathic pain o...
Saved in:
Main Authors: | Wang Xiaoping, Li Xiaojia, Huang Bin, Ma Shuai |
---|---|
Format: | article |
Language: | EN |
Published: |
De Gruyter
2016
|
Subjects: | |
Online Access: | https://doaj.org/article/5583841c648a4ac6bc5740f06e939308 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Nanotechnology-Based Targeting of mTOR Signaling in Cancer
by: Yoon MS
Published: (2020) -
Dual Targeting by Inhibition of Phosphoinositide-3-Kinase and Mammalian Target of Rapamycin Attenuates the Neuroinflammatory Responses in Murine Hippocampal Cells and Seizures in C57BL/6 Mice
by: Preeti Vyas, et al.
Published: (2021) -
Cerebral mTOR signal and pro-inflammatory cytokines in Alzheimer’s disease rats
by: Wang Xu, et al.
Published: (2016) -
mTOR pathway: A potential therapeutic target for spinal cord injury
by: Yi Ding, et al.
Published: (2022) -
Rapamycin attenuates PLA2R activation-mediated podocyte apoptosis via the PI3K/AKT/mTOR pathway
by: Terry Ting-Yu Chiou, et al.
Published: (2021)